This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Obsessive-Compulsive Disorder With Non-24-Hour Sleep-Wake Syndrome

Shigeru Morinobu, Hidehisa Yamashita, Shigeto Yamawaki, Kazuhide Tanaka, and Masako Ohkawa

Published: September 23, 2002

Article Abstract

Letter to the Editor

Sir: Previous reports have indicated that risperidone augmentation of serotonin reuptake inhibitor (SRI) treatment is effective in patients with SRI-resistant obsessive-compulsive disorder (OCD). Moreover, improvement in the quality of sleep by risperidone is increasingly reported. We present a case of a male OCD patient with non-24-hour sleep-wake syndrome who experienced a marked reduction in OCD symptoms as well as sleep-wake disturbance by the addition of risperidone to fluvoxamine.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 63

Quick Links: